BiotechTube

Fluconazole + Micafungin

ApprovedWithdrawn
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Candidiasis

Conditions

Candidiasis, Sepsis

Trial Timeline

Aug 1, 2006 → Dec 1, 2008

NCT ID
NCT00304772

About Fluconazole + Micafungin

Fluconazole + Micafungin is a approved stage product being developed by Astellas Pharma for Candidiasis. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT00304772. Target conditions include Candidiasis, Sepsis.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT00304772ApprovedWithdrawn

Competing Products

20 competing products in Candidiasis

See all competitors
ProductCompanyStageHype Score
MicafunginAstellas PharmaPhase 1
33
Isavuconazole + Caspofungin + VoriconazoleAstellas PharmaPhase 3
77
Micafungin + fluconazoleAstellas PharmaPhase 3
77
Micafungin (Mycamine)Astellas PharmaPhase 1
33
Micafungin + CaspofunginAstellas PharmaPhase 3
77
Micafungin + FluconazoleAstellas PharmaPhase 3
77
MicafunginAstellas PharmaPhase 2
52
micafungin + caspofunginAstellas PharmaPhase 3
77
micafungin + amphotericin B deoxycholateAstellas PharmaPhase 3
77
FK463Astellas PharmaPhase 2
52
Micafungin + Liposomal Amphotericin BAstellas PharmaPhase 3
77
SHR8008 + FluconazoleJiangsu Hengrui MedicinePhase 3
77
SHR8008 capsule + Fluconazole capsuleJiangsu Hengrui MedicinePhase 3
77
L-743,872MerckPre-clinical
23
CaspofunginMerckPhase 2
52
L-743,872MerckPhase 2
52
Caspofungin + Amphotericin B DeoxycholateMerckPhase 2
52
Caspofungin acetate + PlaceboMerckPhase 2
52
Caspofungin + Normal SalineMerckApproved
85
caspofungin acetateMerckPhase 3
77

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85